Latest Articles
- It’s time to consider pharmacotherapy for obesity
Consider using chronic weight-loss medications as adjunctive therapy if lifestyle and behavioral strategies are ineffective.
- ERAAs for menopause treatment: Welcome the ‘designer estrogens’
These drugs stimulate estrogen receptors in some tissues and inhibit them in others, enabling tailored treatment.
- Drug reaction or metastatic lung cancer?
Imaging shows nodules randomly distributed throughout both lungs, a paradoxical reaction to drug therapy.
- To have not and then to have: A challenging immune paradox
The immune reactivation syndrome can occur when the immune system in an immunosuppressed patient with a partially controlled indolent infection is suddenly normalized.
- Fall risk and anticoagulation for atrial fibrillation in the elderly: A delicate balance
The decision-making process is complex and should be shared with the patient and the patient’s family and caregivers.
- Pharmacotherapy for obesity: What you need to know
Weight-loss drugs are not magic pills, but they can help when used along with diet, exercise, and other lifestyle changes.
Benign prostatic hyperplasia: Evaluation and medical management in primary careEffective medical therapy is available but underutilized in the primary care setting.
- Diagnosis and treatment of hyperkalemia
It is most common in patients with renal impairment, can be life-threatening, and requires a multidisciplinary approach.
- What is the role of roflumilast in chronic obstructive pulmonary disease?
It has been shown to reduce acute exacerbations in patients with severe disease.
- Whether to anticoagulate: Toward a more reasoned approach
The patient’s life expectancy and personal preferences are important and affect the decision.
